Quick Answer
Theravance Biopharma, Inc. reported Shares Outstanding of 51.07 million shares for fiscal year 2025.
Theravance Biopharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 51.07M | +3.2% |
| 2024 | 49.47M | +2.9% |
| 2023 | 48.09M | -26.3% |
| 2022 | 65.23M | -12.4% |
| 2021 | 74.44M | +15.7% |
| 2020 | 64.33M | +12.8% |
| 2019 | 57.02M | +2.4% |
| 2018 | 55.68M | +2.4% |
| 2017 | 54.38M | +2.9% |
| 2016 | 52.83M | +39.1% |
| 2015 | 37.98M | +17.9% |
| 2014 | 32.22M | — |
| 2013 | 0 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 50.67M | +3.0% | +0.6% |
| June 30, 2025 | 50.36M | +2.9% | +0.7% |
| March 31, 2025 | 50.00M | +3.0% | +1.1% |
| December 31, 2024 | 49.47M | +2.9% | +0.6% |
| September 30, 2024 | 49.17M | -3.2% | +0.5% |
| June 30, 2024 | 48.92M | -8.9% | +0.7% |
| March 31, 2024 | 48.57M | -19.8% | +1.0% |
| December 31, 2023 | 48.09M | -26.3% | -5.4% |
- Theravance Biopharma, Inc. showed an increase of +3.2% in Shares Outstanding compared to the prior fiscal year.
- The most recent figure is from Theravance Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: